Dec 03, 2018
Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH
Nov 15, 2018
Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound
Nov 12, 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Nov 02, 2018
Autolus Therapeutics to Present New Data at the ASH Annual Meeting
Oct 30, 2018
Arix Bioscience plc - Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011
Oct 25, 2018
Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018
Oct 24, 2018
Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering
Oct 19, 2018
Arix Bioscience plc: LogicBio Prices Nasdaq IPO
Oct 11, 2018
Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound
Oct 10, 2018
Arix Bioscience plc: Update on LogicBio Proposed Initial Public Offering in the United States
Oct 01, 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Jul 30, 2018
Arix Bioscience plc: Interim Results for the Six Months Ended 30 June 2018
Jun 08, 2018
Arix Bioscience plc: Update on Autolus Proposed Initial Public Offering in the United States
Jun 04, 2018
Arix Bioscience to Present at Jefferies 2018 Global Healthcare Conference in New York
May 31, 2018
Arix Bioscience Forms Strategic Collaboration with Evotec AG and Fred Hutchinson Cancer Research Center to Foster New Companies in Cancer and Infectious Diseases
May 08, 2018
Arix Bioscience plc: Autolus Files for Proposed Initial Public Offering in the United States